Jury Faults Dow Chemical In Breast-Implant Trial; Louisiana Class-Action Suit to Enter 2nd Phase

The first jury ever to hear a class-action lawsuit filed over silicone breast implants found yesterday that Dow Chemical Co. did not properly test the material for safety in humans and covered up problems with the devices.

After 17 hours of deliberations over two days, the jurors answered yes to all seven questions posed in a case involving 1,800 Louisiana women claiming a range of ailments of the immune system resulting in pain and fatigue.

The decision marks the end of the first phase of a four-phase trial in state court. In the second phase, which starts next month, jurors will hear testimony about whether the implants caused the health problems suffered by a subset of eight ...

More articles like this:

Loading
We're searching over:
  • 60 million articles
  • 3,500 publications


Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) Register Register